182 related articles for article (PubMed ID: 35117482)
1. FoxP3 promotes lymph node metastasis in patients with papillary thyroid carcinoma complicated with Hashimoto's thyroiditis.
Zeng R; Lyu Y; Niu H; Yang K; Yan X
Transl Cancer Res; 2020 Mar; 9(3):1337-1350. PubMed ID: 35117482
[TBL] [Abstract][Full Text] [Related]
2. Positive effect of RORγt on the prognosis of thyroid papillary carcinoma patients combined with Hashimoto's thyroiditis.
Zeng R; Lyu Y; Zhang G; Shou T; Wang K; Niu H; Yan X
Am J Transl Res; 2018; 10(10):3011-3024. PubMed ID: 30416647
[TBL] [Abstract][Full Text] [Related]
3. Analysis of regulatory T cells frequency in peripheral blood and tumor tissues in papillary thyroid carcinoma with and without Hashimoto's thyroiditis.
Liu Y; Yun X; Gao M; Yu Y; Li X
Clin Transl Oncol; 2015 Apr; 17(4):274-80. PubMed ID: 25387566
[TBL] [Abstract][Full Text] [Related]
4. Decreased proportions of CD4 + IL17+/CD4 + CD25 + CD127- and CD4 + IL17+/CD4 + CD25 + CD127 - FoxP3+ T cells in children with autoimmune thyroid diseases (.).
Bossowski A; Moniuszko M; Idźkowska E; Grubczak K; Singh P; Bossowska A; Diana T; Kahaly GJ
Autoimmunity; 2016 Aug; 49(5):320-8. PubMed ID: 27206624
[TBL] [Abstract][Full Text] [Related]
5. [Role of CD4+ CD25+ regulatory T cells in peripheral blood from patients with papillary thyroid carcinoma].
Shi J; Zhou J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Nov; 26(21):965-9, 972. PubMed ID: 23373232
[TBL] [Abstract][Full Text] [Related]
6. T cell exhaustion is associated with the risk of papillary thyroid carcinoma and can be a predictive and sensitive biomarker for diagnosis.
Zhu C; Dai Y; Zhang H; Ruan Y; Zhou Y; Dai Y; Fan L; Jia T; Lu H; Chen Q
Diagn Pathol; 2021 Aug; 16(1):84. PubMed ID: 34465342
[TBL] [Abstract][Full Text] [Related]
7. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis.
Han LT; Hu JQ; Ma B; Wen D; Zhang TT; Lu ZW; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
Diagn Pathol; 2019 Jun; 14(1):52. PubMed ID: 31159823
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological characterization and prognostic implication of FOXP3 and CK19 expression in papillary thyroid carcinoma and concomitant Hashimoto's thyroiditis.
Mohamed SY; Ibrahim TR; Elbasateeny SS; Abdelaziz LA; Farouk S; Yassin MA; Embaby A
Sci Rep; 2020 Jun; 10(1):10651. PubMed ID: 32606302
[TBL] [Abstract][Full Text] [Related]
9. The characteristics and risk factors of central compartment lymph node metastasis in cN0 papillary thyroid carcinoma coexistent with Hashimoto's thyroiditis.
Jin K; Li L; Liu Y; Wang X
Gland Surg; 2020 Dec; 9(6):2026-2034. PubMed ID: 33447553
[TBL] [Abstract][Full Text] [Related]
10. IL-17 A correlates with disease progression in papillary thyroid carcinoma.
Banerjee S; Nahar U; Dahiya D; Gupta R; Mukherjee S; Sachdeva N; Sood A; Dey P; Radotra B; Bhansali A
Diagn Pathol; 2023 Aug; 18(1):93. PubMed ID: 37563607
[TBL] [Abstract][Full Text] [Related]
11. Dioscin alleviates hashimoto's thyroiditis by regulating the SUMOylation of IRF4 to promote CD4
Yongjun C; Nan Q; Yumeng S; Xiaowen J; Weibo W
Autoimmunity; 2021 Feb; 54(1):51-59. PubMed ID: 33274645
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Liu Y; Lv H; Zhang S; Shi B; Sun Y
Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817
[TBL] [Abstract][Full Text] [Related]
13. Hashimoto's thyroiditis attenuates progression of papillary thyroid carcinoma: deciphering immunological links.
Sulaieva O; Selezniov O; Shapochka D; Belemets N; Nechay O; Chereshneva Y; Tsomartova D; Ivanova M
Heliyon; 2020 Jan; 6(1):e03077. PubMed ID: 31938743
[TBL] [Abstract][Full Text] [Related]
14. Role of cytotoxic T cells and PD-1 immune checkpoint pathway in papillary thyroid carcinoma.
Banerjee S; Nahar U; Dahiya D; Mukherjee S; Dey P; Gupta R; Radotra B; Sachdeva N; Sood A; Bhadada SK; Bhansali A
Front Endocrinol (Lausanne); 2022; 13():931647. PubMed ID: 36518249
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer.
French JD; Weber ZJ; Fretwell DL; Said S; Klopper JP; Haugen BR
J Clin Endocrinol Metab; 2010 May; 95(5):2325-33. PubMed ID: 20207826
[TBL] [Abstract][Full Text] [Related]
16. Lymph node metastasis of papillary thyroid carcinoma in the context of Hashimoto's thyroiditis.
Wang L; Chen J; Yuan X; Wang J; Sun L; Jiang J; Zhang L; Liu M; Zhou Q
BMC Endocr Disord; 2022 Jan; 22(1):12. PubMed ID: 34986823
[TBL] [Abstract][Full Text] [Related]
17. SIRT1-Regulated Abnormal Acetylation of FOXP3 Induces Regulatory T-Cell Function Defect in Hashimoto's Thyroiditis.
Yang X; Lun Y; Jiang H; Liu X; Duan Z; Xin S; Zhang J
Thyroid; 2018 Feb; 28(2):246-256. PubMed ID: 29336238
[TBL] [Abstract][Full Text] [Related]
18. The possible role of CD4⁺CD25(high)Foxp3⁺/CD4⁺IL-17A⁺ cell imbalance in the autoimmunity of patients with Hashimoto thyroiditis.
Xue H; Yu X; Ma L; Song S; Li Y; Zhang L; Yang T; Liu H
Endocrine; 2015 Dec; 50(3):665-73. PubMed ID: 25771887
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of the Impact of Hashimoto Thyroiditis on Papillary Thyroid Carcinoma Progression: Relationship with the Tumor Immune Microenvironment.
Sulaieva O; Chernenko O; Selesnov O; Nechay O; Maievskyi O; Falalyeyeva T; Kobyliak N; Tsyryuk O; Penchuk Y; Shapochka D
Endocrinol Metab (Seoul); 2020 Jun; 35(2):443-455. PubMed ID: 32615729
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T cells and plasmacytoid dendritic cells contribute to the immune escape of papillary thyroid cancer coexisting with multinodular non-toxic goiter.
Yu H; Huang X; Liu X; Jin H; Zhang G; Zhang Q; Yu J
Endocrine; 2013 Aug; 44(1):172-81. PubMed ID: 23264145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
